Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evia Medical Technologies was a UK-based medical device company that developed, manufactured, and distributed devices across multiple healthcare segments, including diabetic care, emergency care, focused ultrasound, orthopedics, aesthetics, low-level laser therapy, and PACS/RIS imaging workflow. Publicly available reports particularly associate the company with the EGM1000, a non-invasive glucose monitoring device marketed for diabetes management. The company appears to have operated primarily as a device commercialization and distribution business rather than a therapeutics developer. UK Companies House records show that Evia Medical Technologies Limited was incorporated on April 1, 2015 and dissolved on May 24, 2022. As a result, it should be treated as a defunct healthcare device company rather than an active biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evia Medical Technologies.